Retinal image reporting with AI help
Part of Eyes & vision, Heart & circulation, Hormones & metabolism clinical trials.
This study tests how well doctors write reports about retinal images when using AI assistance versus doing it on their own. It aims to see if AI helps make reports more accurate and consistent, which could improve care for patients with eye conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a board-certified ophthalmologist or ophthalmology trainee with experience reading eye images.
- You can independently write eye-exam reports based on photos of the back of the eye.
- You have not been part of creating or testing the AI system used in this study.
- You are willing and able to complete the assigned report-writing tasks on time.
- You are available to participate and can give your consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses artificial intelligence to analyze eye images and help doctors diagnose eye diseases. It looks at images from routine care to train and test the AI system.
This study uses an AI program called DRISTi to screen for diabetic eye disease by taking pictures of the back of your eye. It's designed for adults with diabetes who haven't had major eye treatments or vision loss.
This study uses eye images and reports from past exams to train a system that can automatically generate reports for fundus diseases. It may help doctors diagnose eye conditions faster and more accurately.
This research tests whether a computer program can help doctors diagnose eye diseases using special scans called OCT. If you have a common retinal condition and have had these scans, you may be eligible to help improve how eye diseases are found.
This trial is testing an automated tool that helps screen for diabetic retinopathy, a complication of diabetes that affects the eyes. The goal is to see if the tool can accurately detect the condition, which may help with early treatment and prevent vision loss.
This trial is testing a new software tool that helps doctors see and assess different parts of the retina in eye scans. It aims to see how well the tool works in people with and without certain retina conditions.
Hear when a new Epiretinal Membrane trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.